| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |